KRM Ayurveda Shares Lists at 28% Premium on NSE SME

KRM Ayurveda made its stock market debut on NSE SME on January 29, 2026, opening at ₹172.10 per share, 28% above its IPO price of ₹135. 

The SME IPO, which raised ₹77.49 crore through a fresh issue of 57.40 lakh shares, received strong investor interest across retail, institutional, and non-institutional segments.

KRM Ayurveda IPO Allotment and Subscription Details

The IPO for KRM Ayurveda was open for subscription from January 21 to January 23, 2026. Final allotment was completed on January 27. The issue was priced between ₹128–135 per share, entirely via fresh issuance.

The IPO saw robust demand, with an overall subscription of 74.27 times. Retail investors subscribed 54.21 times, Qualified Institutional Buyers (QIBs) 63.31 times, and Non-Institutional Investors 135.37 times, reflecting wide interest across investor categories.

KRM Ayurveda Listing Performance

Shares of KRM Ayurveda opened at ₹172.10 on the NSE SME on January 29, offering a 28% return to IPO allottees. 

The listing performance indicates strong market acceptance on debut day, aligning the company’s stock price above the issue price.

KRM Ayurveda Utilisation of IPO Proceeds

Funds raised through the IPO will support multiple corporate initiatives including:

• Expanding telemedicine infrastructure
• Upgrading technology systems
• Repayment of borrowings
• Meeting working capital requirements
• Other general corporate purposes

Read More: Cochin Shipyard Declares ₹3.50 Interim Dividend: What Is the Record Date and Payment Date?

Conclusion

KRM Ayurveda’s SME IPO listing demonstrated strong investor interest and positive initial price movement. The capital raised is expected to aid business expansion and technology upgrades while maintaining operational growth.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.